MRES (Institute of Biomedical Research) Scaled Net Operating Assets: 0.98 (As of Dec. 2010)


What is Institute of Biomedical Research Scaled Net Operating Assets?

Institute of Biomedical Research MRES Scaled Net Operating Assets is 0.98 as of Dec. 2010.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Institute of Biomedical Research's operating assets for the quarter that ended in Dec. 2010 was $0.66 Mil. Institute of Biomedical Research's operating liabilities for the quarter that ended in Dec. 2010 was $0.00 Mil. Institute of Biomedical Research's Total Assets for the quarter that ended in Sep. 2010 was $0.67 Mil. Therefore, Institute of Biomedical Research's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2010 was 0.98.

Institute of Biomedical Research Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Institute of Biomedical Research's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Institute of Biomedical Research Scaled Net Operating Assets Chart

Institute of Biomedical Research Annual Data
Trend Dec03 Dec04 Mar06 Mar07 Mar08 Mar09 Mar10
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.00 -0.20 0.00 0.72 0.72

Institute of Biomedical Research Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.48 0.75 8.54 0.88 0.98

MRES vs HSTC, NTRR, VITIF: Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, Institute of Biomedical Research's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Institute of Biomedical Research Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Institute of Biomedical Research's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Institute of Biomedical Research's Scaled Net Operating Assets falls into.


Institute of Biomedical Research Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Institute of Biomedical Research's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2010 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2010 )
=(Operating Assets (A: Mar. 2010 )-Operating Liabilities (A: Mar. 2010 ))/Total Assets (A: Mar. 2009 )
=(0.076-0.02)/0.078
=0.72

where

Operating Assets(A: Mar. 2010 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.076 - 0
=0.076

Operating Liabilities(A: Mar. 2010 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.422 - 0 - 0.402
=0.02

Institute of Biomedical Research's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2010 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2010 )
=(Operating Assets (Q: Dec. 2010 )-Operating Liabilities (Q: Dec. 2010 ))/Total Assets (Q: Sep. 2010 )
=(0.655-0)/0.668
=0.98

where

Operating Assets(Q: Dec. 2010 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.655 - 0
=0.655

Operating Liabilities(Q: Dec. 2010 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.461 - 0 - 0.461
=0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.98 mean?
Institute of Biomedical Research (MRES) has a Scaled Net Operating Assets of 0.98 as of Dec. 2010. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Institute of Biomedical Research and its competitors.
Is Institute of Biomedical Research's Scaled Net Operating Assets too high?
Institute of Biomedical Research's current Scaled Net Operating Assets is 0.98.
How does Institute of Biomedical Research's Scaled Net Operating Assets compare to HSTC and NTRR?
Institute of Biomedical Research's Scaled Net Operating Assets of 0.98 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Institute of Biomedical Research and its competitors. Institute of Biomedical Research's current Scaled Net Operating Assets is 0.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Institute of Biomedical Research stock overvalued right now?
Institute of Biomedical Research (MRES) has a current Scaled Net Operating Assets of 0.98. The current Scaled Net Operating Assets is 0.98. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Institute of Biomedical Research (MRES), the current Scaled Net Operating Assets is 0.98 as of Dec. 2010. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Institute of Biomedical Research Business Description

Address Dubai Science Park, 13th Floor, South Tower, Dubai, ARE, 416452
Institute of Biomedical Research Corp is a biomedical research and development company. The company is focused on alternative plant-based food and medicine and mental health therapeutic research. The company uses brand name M2Bio Sciences engaged in deploying artificial intelligence, science and medicine, clinical research, and emerging technologies.